Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
about
Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1Insulin resistance in clinical and experimental alcoholic liver diseaseIn vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).Changes in gene expression associated with FTO overexpression in mice.Genome-wide linkage analysis of QTL for growth and body composition employing the PorcineSNP60 BeadChip.Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet.Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.Effects of high fat feeding on liver gene expression in diabetic goto-kakizaki rats.Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases.Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation.Effect of BI-1 on insulin resistance through regulation of CYP2E1.High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression.Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis.CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.Transcription Factor EB Controls Metabolic Flexibility during Exercise.Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic DiseasesThe Contribution of Singlet Oxygen to Insulin Resistance.Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice.Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.The intestinal microbiota regulates body composition through NFIL3 and the circadian clock.Toxicological Implications of Mitochondrial Localization of CYP2E1.Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model.Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats.The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.
P2860
Q26799149-844412A1-EC59-4973-8DFF-16AA7703F97AQ26865988-71AD8746-EB39-4414-9EA1-C914FD2B4358Q30452333-FF4CD339-EAF6-4DDF-ABBE-C9A4B55BDDBCQ33632126-F747F978-798D-4782-9D4E-88DAD55D43EFQ34274193-C81BDDFA-5C09-4018-AC88-B96D4451CE05Q34519309-94A46065-3610-4518-B8B3-8A8270CBC3C3Q35084113-A364B56A-CAD9-4B74-8BEB-C3072A3E505BQ36243417-ED2ED5DC-1B91-4B1B-9CDE-53BC32E87BD2Q36450303-5A5547FD-BF08-41BC-961B-A9D091826563Q36590615-25193BA2-F555-4386-A9A3-090D6E4390DCQ36795964-CCBB94E3-BF90-4AAB-AEAD-82E37595CFF5Q37220092-081757A5-58F8-4424-B81A-DB46C40041B5Q37337788-59B1668C-E448-431E-8F75-5A3913F87A9AQ37384563-DF9F23F7-0B6B-4301-BA18-5C6DEF0FAC53Q37384997-8D3652A4-ECD8-4E16-BD6B-F726106CD70FQ37554361-41D9BB37-BC4B-404F-9757-D263C5485EADQ37564661-96299A4E-62F8-4C74-AAAA-7E576849A9ACQ37590472-0FF3B85D-61B7-4453-AB0C-F781E19AA631Q38687132-DC228E2D-35C4-4062-9081-3248047478E9Q38763928-5C7D9298-DC00-4A91-BA71-DCDA960C683FQ42730512-D59ACF92-F6EB-43E5-B3FA-60E3A423C062Q46237013-6C56BDD0-2480-4562-A00E-7BBD81D9AD65Q46734844-2267C61C-0BD7-49D9-A459-85C89EEEE4E6Q47163566-A65A0D26-5FDA-41D9-A686-466D55492AA9Q47909554-0A4115F9-F11C-46B7-9230-89BC75C20ABCQ51164359-87818022-CF00-462C-B768-ADF9ED6441B1Q52316734-6C94B430-2C83-496B-92F4-BE1ED831125CQ52657738-7A4E8F28-3F46-4E43-8752-E7E1079FAF4DQ55450597-FE714D45-0118-4487-A649-3492D2FF5E45
P2860
Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@ast
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@en
type
label
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@ast
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@en
prefLabel
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@ast
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@en
P2093
P2860
P1476
Cytochrome P-450 CYP2E1 knocko ...... obesity and insulin resistance
@en
P2093
Chava Harel
Eddy Karnieli
Haihong Zong
Jeffrey E Pessin
Michal Armoni
P2860
P304
P356
10.1152/AJPENDO.00258.2011
P577
2011-12-20T00:00:00Z